TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Arctic Bioscience AS
Closing information (x1000 EUR)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
3,003
|
3,256
|
2,157 |
| Financial expenses |
209
|
0
|
213 |
| Earnings before taxes |
-4,049
|
-3,232
|
-4,269 |
| Total assets |
26,711
|
31,131
|
34,238 |
| Current assets |
11,846
|
18,841
|
26,764 |
| Current liabilities |
3,527
|
3,840
|
2,098 |
| Equity capital |
23,002
|
27,291
|
32,141 |
| - share capital |
226
|
232
|
244 |
| Employees (average) | 17 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
86.1%
|
87.7%
|
93.9% |
| Turnover per employee | 192 | ||
| Profit as a percentage of turnover |
-134.8%
|
-99.3%
|
-197.9% |
| Return on assets (ROA) |
-14.4%
|
-10.4%
|
-11.8% |
| Current ratio |
335.9%
|
490.7%
|
1275.7% |
| Return on equity (ROE) |
-17.6%
|
-11.8%
|
-13.3% |
| Change turnover |
-46
|
1,212
|
102 |
| Change turnover % |
-2%
|
59% | |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.